Status:
NOT_YET_RECRUITING
StOPping Hypertension and imprOving Children's Lives After KidnEy TranSplantation
Lead Sponsor:
Hannover Medical School
Collaborating Sponsors:
Heidelberg; University of Heidelberg
Berlin; Charité
Conditions:
Arterial Hypertension
Kidney Transplant; Complications
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Cardiovascular (CV) disease is a major morbidity in children after kidney transplantation (KTx), limiting life expectancy and impairing graft function. Arterial hypertension (AH) is the dominant CV ri...
Eligibility Criteria
Inclusion
- Kidney transplantation \>12 months ago
- Arterial hypertension
Exclusion
- Cardiac malformation
- Treatment for a rejection episode within three months prior to inclusion
Key Trial Info
Start Date :
September 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT06589947
Start Date
September 16 2024
End Date
March 1 2029
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.